The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint
Biopharmaceutical Development & Production Week

Registration

Save $100 if you register by February 3.
» View Pricing

Download Brochure

Add to Outlook Calendar

Find Another IBC Event

Process & Product Validation

CSS

Alternate Language Options:

  • Japanese
  • Korean
  • Taiwanese
  • Chinese
  • English

Moving Towards a LifeCycle and Risk-based Approach for Continuous Validation

February 27 - 28, 2012 · Hilton San Diego Bayfront Hotel · San Diego, CA

Event Overview

Event Overview

This conference provides insights into the interpretation and implementation of FDA's Process Validation Guidance and QbD approaches, while examining the roles and impact of knowledge management and quality risk management on continuous verification.

  • When considering process validation, are you confounded by the question of "Is 3 batches sufficient"?
  • Are you confident that your process is capable of consistently delivering the same quality?
  • How do you design the process, demonstrate that it works, and continuously monitor the process to ensure consistency?
  • How do you interpret and implement the new Guidance into your existing validation program?

Learn answers to these questions and more at IBC's Process and Product Validation conference.

"Great conference with many valuable topics covered." - M. Kane, Associate Director, Process Statistics, HGSI

Keynote Presentations

David Chang, Ph.D.

Biologics Product & Process Lifecycle Management: Genentech / Roche Experience
David Chang, Ph.D.
Senior Director, Global Biologics Manufacturing Science & Technology
Genentech, Inc., a member of the Roche group

Greg Liposky, Ph.D.

Facility Fit Analysis – The First Step in a Long Journey
Greg Liposky, Ph.D.
Vice President & General Manager, Site Operations
MedImmune

Featured Presentation

Amit Banerjee, Ph.D.

Key Elements of Process Design: Risk Assessments, Design Space and Control Strategy
Amit Banerjee, Ph.D.
Research Fellow, Global Biologics
Pfizer, Inc.

Plus, in-Depth Coverage on:

  • Progression of Process Validation & Recent Trends
  • Linking QbD, Design Space and New FDA Guidance
  • Interpreting and Implementing the New FDA PV Guidance
  • Process Knowledge and Lifecycle Management in Enabling Continuous Verification
  • Trouble-Shooting Chalenges in Process Validation
  • Case Studies and Strategies for Manufacturing Facility Control, Protection and Remediation

» View the agenda